Filing Flows › Xtant Medical Holdings (XTNT) › How it makes money
How Xtant Medical Holdings (XTNT) makes money
Xtant Medical Holdings (XTNT) made $23.0M of revenue in the second quarter 2026 (Q2 2026), -24% from a year earlier. Orthobiologics brought in $17.4M (75%); Spinal Implant brought in $5.7M (25%).
Drawing the Sankey…
Revenue by segment, Q2 2026
| Segment | Revenue | Share | Q/Q | Y/Y |
|---|---|---|---|---|
| Orthobiologics | $17.4M | 75.4% | +11% | -10% |
| Spinal Implant | $5.7M | 24.6% | +8% | -49% |
Where each dollar of revenue goes
| Line | Q2 2026 | % of revenue |
|---|---|---|
| Revenue | $23.0M | 100.0% |
| Income tax | $73K | 0.3% |
Revenue, quarter by quarter
| Quarter | Revenue | Y/Y |
|---|---|---|
| Q2 2026 | $23.0M | -35% |
| Q1 2026 | $20.9M | -36% |
| Q4 2025 | $32.4M | +3% |
| Q3 2025 | $33.3M | +19% |
| Q2 2025 | $35.4M | +18% |
| Q1 2025 | $32.9M | +18% |
| Q4 2024 | $31.5M | +12% |
From Xtant Medical Holdings' 10-Q filed Aug 11, 2026 (on EDGAR).
Questions
How does Xtant Medical Holdings make money?
Xtant Medical Holdings (XTNT) made $23.0M of revenue in the second quarter 2026 (Q2 2026), -24% from a year earlier. Orthobiologics brought in $17.4M (75%); Spinal Implant brought in $5.7M (25%).
What is Xtant Medical Holdings' biggest business?
Orthobiologics: $17.4M in the second quarter 2026, 75% of revenue, -10% from a year earlier.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.